{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:33:00Z","timestamp":1790836380983,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":761,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Autoimmune hepatitis (AIH) is defined as a chronic liver disease with loss of tolerance against liver tissue eventually leading to cirrhosis if left untreated. 80%-90% of patients can be treated with a life-long immunosuppression. Unfortunately, there are strong drug-related side effects and steroid-refractory patients. Therefore, there is a need for a model system to investigate the complex immunopathogenesis of this chronic disease and subsequently to develop new therapeutic interventions. We developed a new model of experimental murine AIH (emAIH) by a self-limited adenoviral infection with the hepatic autoantigen formiminotransferase cyclodeaminase (FTCD). After an initial transient hepatitis there was a chronic evolving AIH, finally leading to portal and lobular fibrosis. We could show that the genetic predisposition provided by the NOD background was essential for creating a fertile field for the development of liver-specific autoimmunity. However, a strong environmental trigger was additionally necessary to initiate the disease. Besides the break of humoral tolerance, T-cell tolerance against hepatic self-antigens was also broken and CD4+ T cells were identified as essential drivers of the disease. As the disease was successfully treated with prednisolone and budesonide, the model will be helpful to develop and test new therapeutic interventions.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion\n                                 <\/jats:bold>\n                                 <jats:bold>: We developed a new murine AIH model closely resembling AIH in patients that explains the mechanisms of AIH pathophysiology. In addition, emAIH provides options to test therapeutic alternatives for patients not achieving remission, with reduced side effects of chronic nonspecific immunosuppression. (Hepatology 2013;58:718\u2013728)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26380","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T23:44:25Z","timestamp":1362786265000},"page":"718-728","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":87,"title":["Genetic Predisposition and Environmental Danger Signals Initiate Chronic Autoimmune Hepatitis Driven by CD4+ T Cells"],"prefix":"10.1097","volume":"58","author":[{"given":"Matthias","family":"Hardtke-Wolenski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Noyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Schlue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Stahlhut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Woller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kuehnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Taubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Jaeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20241201","doi-asserted-by":"crossref","first-page":"12101218","DOI":"10.1016\/j.jhep.2009.01.020","article-title":"Autoimmune hepatitis in Italy: the Bologna experience.","volume":"50","author":"Muratori","year":"2009","journal-title":"J Hepatol"},{"issue":"Suppl","key":"R3-29-20241201","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1016\/S0168-8278(10)61100-2","article-title":"Persisting histological inflammation in autoimmune hepatitis (AIH) despite biochemical remission: assessment of factors influencing outcome.","volume":"52","author":"Hoeroldt","year":"2010","journal-title":"J Hepatol"},{"key":"R4-29-20241201","first-page":"7079","article-title":"Mouse models for experimental autoimmune hepatitis: limits and chances.","volume":"28","author":"HardtkeWolenski","year":"2010","journal-title":"Dig Dis"},{"key":"R5-29-20241201","doi-asserted-by":"crossref","first-page":"816822","DOI":"10.1002\/hep.1840180411","article-title":"Genetic predispositions for the immunological features of chronic active hepatitis.","volume":"18","author":"Czaja","year":"1993","journal-title":"Hepatology"},{"key":"R6-29-20241201","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1002\/hep.510310110","article-title":"Cytotoxic T lymphocyte antigen4 (CTLA4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.","volume":"31","author":"Agarwal","year":"2000","journal-title":"Hepatology"},{"key":"R7-29-20241201","doi-asserted-by":"crossref","first-page":"11831187","DOI":"10.1016\/0140-6736(91)92858-Y","article-title":"Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.","volume":"337","author":"Vento","year":"1991","journal-title":"Lancet"},{"key":"R8-29-20241201","doi-asserted-by":"crossref","first-page":"11981200","DOI":"10.1136\/gut.32.10.1198","article-title":"Severe chronic active hepatitis (autoimmune type) mimicked by coinfection of hepatitis C and human immunodeficiency viruses.","volume":"32","author":"Berk","year":"1991","journal-title":"Gut"},{"key":"R9-29-20241201","first-page":"911","article-title":"Persistent measles virus genome in autoimmune chronic active hepatitis.","volume":"2","author":"Robertson","year":"1987","journal-title":"Lancet"},{"key":"R10-29-20241201","doi-asserted-by":"crossref","first-page":"819820","DOI":"10.1016\/0092-8674(87)90507-1","article-title":"Molecular mimicry and autoimmune disease.","volume":"50","author":"Oldstone","year":"1987","journal-title":"Cell"},{"key":"R11-29-20241201","doi-asserted-by":"crossref","first-page":"433442","DOI":"10.1016\/1074-7613(94)90074-4","article-title":"MHC class Irestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1deleted recombinant adenoviruses.","volume":"1","author":"Yang","year":"1994","journal-title":"Immunity"},{"key":"R12-29-20241201","doi-asserted-by":"crossref","first-page":"14091422","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.","volume":"205","author":"Holdener","year":"2008","journal-title":"J Exp Med"},{"key":"R13-29-20241201","doi-asserted-by":"crossref","first-page":"10661074","DOI":"10.1002\/hep.20109","article-title":"A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens.","volume":"39","author":"Lapierre","year":"2004","journal-title":"Hepatology"},{"key":"R14-29-20241201","doi-asserted-by":"crossref","first-page":"975986","DOI":"10.1053\/j.gastro.2010.05.075","article-title":"Effects and regulation of autoreactive CD8() T cells in a transgenic mouse model of autoimmune hepatitis.","volume":"139","author":"Zierden","year":"2010","journal-title":"Gastroenterology"},{"key":"R15-29-20241201","first-page":"593598","article-title":"Naked DNA delivered intraportally expresses efficiently in hepatocytes.","volume":"3","author":"Budker","year":"1996","journal-title":"Gene Ther"},{"key":"R16-29-20241201","doi-asserted-by":"crossref","first-page":"11981206","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis.","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"R17-29-20241201","doi-asserted-by":"crossref","first-page":"989997","DOI":"10.1053\/j.gastro.2008.05.078","article-title":"Intrahepatic murine CD8 Tcell activation associates with a distinct phenotype leading to Bimdependent death.","volume":"135","author":"Holz","year":"2008","journal-title":"Gastroenterology"},{"key":"R18-29-20241201","doi-asserted-by":"crossref","first-page":"14281440","DOI":"10.1016\/S0016-5085(99)70508-1","article-title":"Induction of cytokine production in naive CD4() T cells by antigenpresenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells.","volume":"116","author":"Knolle","year":"1999","journal-title":"Gastroenterology"},{"key":"R20-29-20241201","doi-asserted-by":"crossref","first-page":"13331343","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD1mediated signaling.","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"key":"R21-29-20241201","doi-asserted-by":"crossref","first-page":"169176","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis.","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"R22-29-20241201","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1016\/j.jaut.2005.11.001","article-title":"Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development.","volume":"26","author":"Lapierre","year":"2006","journal-title":"J Autoimmun"},{"key":"R23-29-20241201","doi-asserted-by":"crossref","first-page":"447485","DOI":"10.1146\/annurev.immunol.23.021704.115643","article-title":"The NOD mouse: a model of immune dysregulation.","volume":"23","author":"Anderson","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R24-29-20241201","doi-asserted-by":"crossref","first-page":"284292","DOI":"10.1038\/ng0395-284","article-title":"Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus.","volume":"9","author":"Bennett","year":"1995","journal-title":"Nat Genet"},{"key":"R25-29-20241201","doi-asserted-by":"crossref","first-page":"189193","DOI":"10.1016\/j.autrev.2010.09.024","article-title":"Autoimmune hepatitis, HLA and extended haplotypes.","volume":"10","author":"Oliveira","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R26-29-20241201","doi-asserted-by":"crossref","first-page":"110127","DOI":"10.1111\/j.1399-0039.2007.00867.x","article-title":"Relative predispositional effects of HLA class II DRB1DQB1 haplotypes and genotypes on type 1 diabetes: a metaanalysis.","volume":"70","author":"Thomson","year":"2007","journal-title":"Tissue Antigens"},{"key":"R27-29-20241201","doi-asserted-by":"crossref","first-page":"235239","DOI":"10.1007\/s00251-006-0099-0","article-title":"Geographical distribution and disease associations of the CD45 exon 6 138G variant.","volume":"58","author":"Ward","year":"2006","journal-title":"Immunogenetics"},{"key":"R28-29-20241201","doi-asserted-by":"crossref","first-page":"12751282","DOI":"10.1093\/hmg\/6.8.1275","article-title":"Insulindependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups.","volume":"6","author":"Marron","year":"1997","journal-title":"Hum Mol Genet"},{"key":"R29-29-20241201","doi-asserted-by":"crossref","first-page":"e4e7","DOI":"10.1016\/j.diabres.2009.04.026","article-title":"TNF 308 GA polymorphism and type 1 diabetes: a metaanalysis.","volume":"85","author":"Feng","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"R30-29-20241201","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cca.2006.02.016","article-title":"Vitamin D receptor polymorphisms and diseases.","volume":"371","author":"Valdivielso","year":"2006","journal-title":"Clin Chim Acta"},{"key":"R31-29-20241201","doi-asserted-by":"crossref","first-page":"851856","DOI":"10.1002\/hep.510300412","article-title":"Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis.","volume":"30","author":"Cookson","year":"1999","journal-title":"Hepatology"},{"key":"R32-29-20241201","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1038\/sj.gene.6363918","article-title":"77 CG mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link.","volume":"4","author":"Vogel","year":"2003","journal-title":"Genes Immun"},{"key":"R33-29-20241201","first-page":"13561362","article-title":"CTLA4CD 28 region polymorphisms in children from families with autoimmune hepatitis.","volume":"62","author":"DjilaliSaiah","year":"2001","journal-title":"Hum Immunol"},{"key":"R34-29-20241201","doi-asserted-by":"crossref","first-page":"126131","DOI":"10.1053\/jhep.2002.30084","article-title":"Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis.","volume":"35","author":"Vogel","year":"2002","journal-title":"Hepatology"},{"key":"R35-29-20241201","doi-asserted-by":"crossref","first-page":"16201624","DOI":"10.1016\/S0140-6736(97)10290-2","article-title":"Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders.","volume":"351","author":"Mason","year":"1998","journal-title":"Lancet"},{"key":"R36-29-20241201","first-page":"9499","article-title":"Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.","volume":"97","author":"Ma","year":"1994","journal-title":"Clin Exp Immunol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26380","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201308000-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:16:22Z","timestamp":1733062582000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201308000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26380","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}